In pancreatic cancer, elevated TXNIP expression leads to repression of malignant transcripts and impairment of metastatic tumorigenesis through the epigenetic reprogramming of chromatin [89]. The gene discussed is TXNIP; the disease is familial pancreatic carcinoma.